Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer
Clinical trial NCT00054132 · COMPLETED
Trial details
- NCT number
- NCT00054132
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2015-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.